Celltrion USA Amends Rights Offering: Total Amount Reduced, Second Payment Date Set
- Celltrion USA amends rights offering decision: total proceeds reduced to KRW 748.58B (USD 509.1M), second payment date set to May 13, 2026
- First tranche: USD 445.8M (Dec 18, 2025); Second tranche: USD 70.3M (May 13, 2026)
- Purpose: Acquisition of US API facility and operating funds (operating USD 7M, securities acquisition USD 509.1M)
- Shareholder allocation, par value USD 0.0001, issuance of 100 new shares plus capital contribution without stock issuance
- Exempt from securities registration as overseas unlisted company
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: [Correction of Description] Decision on Paid-in Capital Increase (Major Management Matters of Subsidiary)
- Company: Celltrion (068270)
- Submission: Celltrion, Inc.
- Receipt: 05-11-2026
- Under KRX KOSPI Market Division